H.C. Starck Financial Performance Surges in 2011, Owners Mull Sale or IPO

H.C. Starck's Ebitda increased 90% for full year 2011, to €190 million ($253 million ), according to figures published by Reuters citing sources close to H.C. Starck. H.C. Starck has not commented on the leaked Ebitda figures. The company has published sales figures showing that its 2011 sales increased 28% to €883.2 million compared with €689.3 million in 2010. The owners of the company, private equity groups Advent and Carlyle, are seeking to sell the group or to launch an IPO, sources told Reuters.  The owners of...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers